I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Keser, F. Doger
10
results:
Search for persons
X
Sorted by: Relevance
Sorted by: Year
?
1
397 THE EFFECTS OF GABAPENTIN COMBINED WITH NITROGLYCERINE ..:
Aydin, O.N.
;
Keser, F. Doger
;
Sekdur, F.
...
European Journal of Pain. 13 (2009) S1 - p. , 2009
Link:
https://doi.org/10.1016/..
?
2
Two different myeloproliferative neoplasms due to JAK2V617F..:
Turgutkaya, A.
;
Yavaşoğlu, İ.
;
Bolaman, Z.
...
Leukemia Research. 85 (2019) - p. S55-S56 , 2019
Link:
https://doi.org/10.1016/..
?
3
Safety, pharmacokinetics, pharmacodynamics, and antitumor a..:
Baranda, Joaquina C.
;
Robbrecht, Debbie
;
Sullivan, Ryan
...
Clinical and Translational Science. 17 (2024) 6 - p. , 2024
Link:
https://doi.org/10.1111/..
?
4
EP08.01-109 TACTI-002: A Phase II Study of Eftilagimod Alph..:
Forster, M.
;
Krebs, M.
;
Majem, M.
...
Journal of Thoracic Oncology. 17 (2022) 9 - p. S395 , 2022
Link:
https://doi.org/10.1016/..
?
5
Hafnium Oxide Nanoparticles Activated By Radiotherapy: Pote..:
Dicker, A.P.
;
Shen, C.
;
De Baere, T.
...
International Journal of Radiation Oncology*Biology*Physics. 105 (2019) 1 - p. S241 , 2019
Link:
https://doi.org/10.1016/..
?
6
Predictive biomarker candidates to delineate efficacy of an..:
Romero-Laorden, N.
;
Doger, B.
;
Hernandez, M.
...
Clinical and Translational Oncology. 18 (2015) 1 - p. 1-8 , 2015
Link:
https://doi.org/10.1007/..
?
7
200P Testing a higher dose (90 mg s.c.) of eftilagimod alph..:
Murillo, S. Morales
;
Forget, F.
;
Solis, E. Segui
...
ESMO Open. 9 (2024) - p. 103222 , 2024
Link:
https://doi.org/10.1016/..
?
8
255TiP AIPAC-003: A randomized, double-blind, placebo-contr..:
Duhoux, F.P.
;
Ibrahim, N.K.
;
Papadamitriou, K.
...
ESMO Open. 8 (2023) 1 - p. 101443 , 2023
Link:
https://doi.org/10.1016/..
?
9
The analysis of TMS brain mapping of plastic changes in sca..:
Gok, K.
;
Doger, E.N.
;
Goztepe, M.B.
...
European Neuropsychopharmacology. 27 (2017) - p. S714 , 2017
Link:
https://doi.org/10.1016/..
?
10
11MO Final data from a phase II study (TACTI-002) of eftila..:
Majem, M.
;
Forster, M.D.
;
Krebs, M.G.
...
Journal of Thoracic Oncology. 18 (2023) 4 - p. S43-S44 , 2023
Link:
https://doi.org/10.1016/..
1-10